Oramed Pharmaceuticals Inc.
DE ˙ DB ˙ US68403P2039
3,24 € ↓ -0,02 (-0,77%)
2026-06-05
DEL PRIS
SecurityDE:OJU1 / Oramed Pharmaceuticals Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership16,018 shares
Latest Disclosed Value $ 54,461
Millennium Management Llc ownership in OJU1 / Oramed Pharmaceuticals Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 16,018 shares of Oramed Pharmaceuticals Inc. (DE:OJU1) valued at $45,251 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 15, 2025 disclosing 0 shares of Oramed Pharmaceuticals Inc.. The current value of the position is $51,898 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 16,018 16,018 54 0.0000
2025-05-15 2025-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 0 -24,381 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 24,381 -22,286 -47.76 59 -47.79 0.0000
2024-11-14 2024-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 46,667 27,210 139.85 114 126.00 0.0001
2024-08-14 2024-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 19,457 19,457 50 0.0000
2023-11-14 2023-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 0 -78,620 -100.00 0 -100.00
2023-08-14 2023-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 78,620 -87,150 -52.57 281 -22.16 0.0001
2023-05-15 2023-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 165,770 -324,433 -66.18 361 -93.88 0.0002
2023-02-14 2022-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 490,203 -12,828 -2.55 5,897 80.89 0.0033
2022-11-14 2022-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 503,031 -77,352 -13.33 3,260 22.65 0.0019
2022-08-15 2022-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 580,383 216,823 59.64 2,658 -15.48 0.0016
2022-05-16 2022-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 363,560 -398,010 -52.26 3,145 -71.08 0.0017
2022-02-14 2021-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 761,570 692,384 1,000.76 10,875 614.99 0.0055
2021-11-15 2021-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 69,186 -132,034 -65.62 1,521 -43.50 0.0009
2021-08-16 2021-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 201,220 45,098 28.89 2,692 69.74 0.0017
2021-05-17 2021-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 156,122 132,605 563.87 1,586 1,486.00 0.0011
2021-02-16 2020-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 23,517 -46,567 -66.44 100 -45.36 0.0001
2020-11-16 2020-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 70,084 70,084 183 0.0002
2020-08-14 2020-06-30 13F ORAMED PHARM COM NEW 68403P203 0 -13,091 -100.00 0 -100.00
2020-05-14 2020-03-31 13F ORAMED PHARM COM NEW 68403P203 13,091 13,091 40 0.0001
2020-02-14 2019-12-31 13F ORAMED PHARM COM NEW 68403P203 0 -15,772 -100.00 0 -100.00
2019-11-14 2019-09-30 13F ORAMED PHARM COM NEW 68403P203 15,772 15,772 50 0.0001
2018-05-15 2018-03-31 13F ORAMED PHARM COM NEW 68403P203 0 -15,849 -100.00 0 -100.00
2018-02-14 2017-12-31 13F ORAMED PHARM COM NEW 68403P203 15,849 15,849 143 0.0002
2016-11-14 2016-09-30 13F ORAMED PHARM COM NEW 68403P203 0 -16,811 -100.00 0 -100.00
2016-08-15 2016-06-30 13F ORAMED PHARM COM NEW 68403P203 16,811 16,811 0.00 140 0.0003
2016-05-16 2016-03-31 13F ORAMED PHARM COM NEW 68403P203 0 -14,364 -100.00 0 -100.00
2016-02-16 2015-12-31 13F ORAMED PHARM COM NEW 68403P203 14,364 14,364 123 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.